Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score

SIMPLE SUMMARY: The Lung Immune Prognostic Index (LIPI) is a score that combines pretreatment dNLR (neutrophils/(leukocytes − neutrophils) and lactate dehydrogenase (LDH) and is correlated with outcomes in patients with non-small-cell lung cancer treated with anti PD-(L)1 but has not been validated...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierro, Monica, Baldini, Capucine, Auclin, Edouard, Vincent, Hélène, Varga, Andreea, Martin Romano, Patricia, Vuagnat, Perrine, Besse, Benjamin, Planchard, David, Hollebecque, Antoine, Champiat, Stéphane, Marabelle, Aurélien, Michot, Jean-Marie, Massard, Christophe, Mezquita, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600023/
https://www.ncbi.nlm.nih.gov/pubmed/36291861
http://dx.doi.org/10.3390/cancers14205078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600023/
https://www.ncbi.nlm.nih.gov/pubmed/36291861
http://dx.doi.org/10.3390/cancers14205078

Ejemplares similares